Creatine for Women Over 40: What the Evidence Actually Says

SUPPLEMENTS & NUTRITION · EVIDENCE REVIEW

Creatine may have one of the largest gaps between its gym-culture reputation and the evidence behind it. For women over 40, the interesting question is not whether creatine is trendy. It is which outcomes have actually been demonstrated, in which women, and under what conditions.

What creatine is, briefly

Creatine is a naturally occurring compound involved in rapid cellular energy recycling. The body makes it, food supplies some of it, and most of the body’s creatine pool is found in skeletal muscle. Creatine monohydrate supplementation can increase creatine stores and has decades of research behind its use for strength and high-intensity exercise.

That established sports-nutrition story is now colliding with a much newer consumer story about menopause, cognition, healthy aging and longevity. Some of that expansion is supported by evidence. Some of it is still ahead of the data.

Why women over 40 are part of the conversation

Female creatine metabolism is influenced by reproductive physiology, and researchers have become increasingly interested in whether supplementation has particular value across menstruation, pregnancy and menopause. A 2025 review of women’s health research described promising findings but also emphasized that perimenopausal data remain limited and that better female-specific trials are needed.

That distinction matters. Hormonal change is a reason to study creatine more carefully in women. It is not proof that every woman over 40 is creatine-deficient or that falling estrogen automatically creates a need for supplementation.

For the larger midlife context, see The Midlife Muscle Conversation Is Bigger Than Weight Loss. Resistance training remains the foundation. A supplement should be evaluated as an addition to that foundation, not a replacement for it.

The strongest women-specific signal: lean mass and strength

A 2026 systematic review and meta-analysis focused specifically on postmenopausal women included seven randomized controlled trials and 608 participants. Overall, creatine was associated with a small increase in lean mass and improved leg-press strength. The clearest benefits appeared when at least 5 g/day of creatine was combined with resistance training. Lower-dose trials without resistance training did not show measurable benefit.

Bone density, however, was unchanged overall. That is an important correction to the increasingly common claim that creatine is already an established bone-health supplement for menopause.

The cognitive angle is interesting, not settled

Creatine also plays a role in brain energy metabolism, which makes cognition a plausible research target. But plausibility and proof are different things.

A recent systematic review of creatine and cognition in older adults found a generally positive signal, particularly for memory and attention, but judged the evidence limited and called for higher-quality clinical trials. The literature is not yet strong enough to describe creatine as a treatment for perimenopausal brain fog.

A small 2025 study of 15 peri- and postmenopausal women reported some improvements, including lower-body strength and sleep quality in the perimenopausal subgroup, but its size and quasi-experimental design make it hypothesis-generating rather than definitive.

What the evidence supports

Strength and lean-mass support when paired with resistance training. This is the clearest reason for a postmenopausal woman to consider creatine.
Exercise performance. Creatine’s broader evidence base for repeated high-intensity work and resistance exercise is well established.
A possible cognitive benefit. Worth watching, but not yet specific enough to promise relief from menopause-related cognitive symptoms.

What the evidence does not establish

Creatine as a menopause treatment. It does not replace individualized menopause care or hormone therapy when that is appropriate.
A proven treatment for brain fog. The cognitive literature is promising but still limited.
A reliable bone-density intervention on its own. The 2026 postmenopausal meta-analysis found no overall bone-density benefit.
That every woman over 40 needs it. The decision still depends on goals, diet, training, tolerance and medical context.

Safety and dosing without the theater

Creatine monohydrate is the form with the deepest research base. Common maintenance protocols in the literature are around 3–5 g/day. Loading can saturate stores faster, but it is optional rather than a requirement.

In the 2026 postmenopausal meta-analysis, adverse events were mild and similar to placebo, and renal markers were unchanged. That does not mean medical context is irrelevant. Anyone with kidney disease, significant medical conditions, pregnancy, or medication questions should discuss supplementation with an appropriate clinician rather than treating a population-level safety finding as individualized clearance.

Creatine can increase body weight as water is stored with creatine in muscle. That is not the same thing as gaining body fat. If the scale is emotionally or clinically loaded for you, knowing that before starting matters.

The E.E.E. buying filter

Evidence: Plain creatine monohydrate is the benchmark. A more expensive form needs evidence that it produces a meaningful advantage, not simply a more elaborate label.

Experience: The useful product is the one you can take consistently without turning it into another complicated ritual. Taste, mixability and gastrointestinal tolerance matter because adherence matters.

Economics: Creatine is a commodity ingredient. Compare cost per 3–5 g serving and look for credible independent quality testing. Paying a large premium for proprietary language does not automatically buy a better outcome.

This is the same logic behind Colostrum Is Suddenly Everywhere. What Are We Actually Buying?: the presence of interesting biology is the beginning of the evaluation, not the end.

The bottom line

For a woman over 40 who resistance-trains and wants to preserve or build strength and lean mass, creatine monohydrate is unusually defensible as supplements go. The newest women-specific evidence strengthens that case, particularly after menopause.

The rest of the story deserves restraint. Cognition is promising. Bone benefits are not established. Perimenopause-specific evidence is still thin. And no powder gets to take credit for the training stimulus doing most of the work.

Sources & further reading

AbundantlyMari evaluates wellness products and claims through Evidence, Experience, and Economics. This article is educational and is not individualized medical advice. Discuss supplement decisions with a qualified healthcare professional when your health history, medications, pregnancy status or kidney function make that appropriate.